Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed No phase listed Observational

Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203

ClinicalTrials.gov ID: NCT02115568

Public ClinicalTrials.gov record NCT02115568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Registry to Assess the Ongoing Safety for Subjects That Have Been Randomized and Completed a Juventas Sponsored Heart Failure Protocol Under IND # 14203

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an exploratory registry that will include subjects who have been randomized to receive JVS-100 treatment (at one of multiple doses) or placebo by one of a number of delivery systems (e.g. endomyocardial injection, retrograde infusion) in a previous Juventas clinical trial.

Study identification

NCT ID
NCT02115568
Recruitment status
Not listed
Study type
Observational
Phase
Not listed
Lead sponsor
Juventas Therapeutics, Inc.
Industry
Enrollment
165 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2014 (Type not available)
Primary completion
Jan 2017 (Estimated)
Completion
Jan 2017 (Estimated)
Last update posted
Apr 16, 2014

2014 – 2017

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
Cardiology, P.C. Birmingham Alabama 35211 —
University of Florida Gainsville Florida 32610-0277 —
Pepin Heart Institute Tampa Florida 33613 —
Iowa Heart Center Des Moines Iowa 50026 —
University of Kentucky Gill Heart Institute Lexington Kentucky 40536 —
Johns Hopkins University Baltimore Maryland 21287 —
Michigan Cardiovascular Institute Saginaw Michigan 48601 —
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 —
Washington University in St. Louis St Louis Missouri 63110 —
Columbia University Medical Center New York New York 10032 —
Summa Health System Akron Ohio 44309 —
The Carl and Edyth Lindner Center for Research & Education at The Christ Hospital Cincinnati Ohio 45219 —
University of Pennsylvania Health System Philadelphia Pennsylvania 19104 —
University of Utah Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02115568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2014 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02115568 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →